methoxsalen PUVA
Selected indexed studies
- Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA). (Am J Hosp Pharm, 1981) [PMID:7020414]
- Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study. (J Pediatr, 1996) [PMID:8969737]
- Clinical pharmacokinetics of methoxsalen and other psoralens. (Clin Pharmacokinet, 1986) [PMID:3512141]
_Worker-drafted node — pending editorial review._
Connections
methoxsalen PUVA is a side effect of
Sources
- Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA). (1981) pubmed
- Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study. (1996) pubmed
- Clinical pharmacokinetics of methoxsalen and other psoralens. (1986) pubmed
- Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report. (1992) pubmed
- Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. (1991) pubmed
- PUVA therapy: current concerns in Japan. (1999) pubmed
- Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis. (2006) pubmed
- The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion. (2003) pubmed
- Long-term efficacy of PUVA treatment in lichen planus: comparison of oral and external methoxsalen regimens. (1987) pubmed
- Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. (1997) pubmed